The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NVDA | +58.27% | +1,328.14% | +70.15% | +486,916% |
| S&P | +19.17% | +69.21% | +11.09% | +445% |
Nvidia deals in programmable graphics-processor technologies. Its major business segments are graphics processing units, media and communications processors, and handheld and consumer electronics.
Nvidia's outstanding growth and sunny prospects make it a growth stock worth investing in.
| Q1 2026 | YOY Change | |
|---|---|---|
| Revenue | $68.13B | 73.2% |
| Gross Profit | $51.09B | 77.9% |
| Gross Margin | 75.00% | 2.0% |
| Market Cap | $4.64T | 57.9% |
| Market Cap / Employee | $110.58M | 0.0% |
| Employees | 42K | 16.7% |
| Net Income | $42.96B | 94.5% |
| EBITDA | $45.11B | 83.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q1 2026 | YOY Change | |
|---|---|---|
| Net Cash | $10.61B | 23.5% |
| Accounts Receivable | $38.47B | 66.8% |
| Inventory | 21.4K | 112.3% |
| Q1 2026 | YOY Change | |
|---|---|---|
| Long Term Debt | $10.04B | 0.6% |
| Short Term Debt | $1.37B | 376.0% |
| Q1 2026 | YOY Change | |
|---|---|---|
| Return On Assets | 75.42% | -6.8% |
| Return On Invested Capital | 39.10% | 12.5% |
| Q1 2026 | YOY Change | |
|---|---|---|
| Free Cash Flow | $21.90B | 40.8% |
| Operating Free Cash Flow | $36.19B | 117.6% |
| Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 35.76 | 49.38 | 46.13 | 38.29 | -21.09% |
| Price to Book | 33.61 | 51.74 | 49.24 | 39.07 | -12.50% |
| Price to Sales | 18.40 | 25.76 | 24.37 | 21.23 | -21.36% |
| Price to Tangible Book Value | 36.36 | 55.92 | 52.66 | 41.59 | -14.73% |
| Price to Free Cash Flow TTM | 38.43 | 59.91 | 59.73 | 55.44 | -5.56% |
| Enterprise Value to EBITDA | 120.84 | 144.63 | 122.70 | 100.51 | -29.23% |
| Free Cash Flow Yield | 2.6% | 1.7% | 1.7% | 1.8% | 5.89% |
| Return on Equity | 115.5% | 109.4% | 107.4% | 101.5% | -14.85% |
| Total Debt | $10.29B | $10.60B | $10.82B | $11.41B | 11.12% |
Nvidia has been the belle of the quarterly earnings ball for quite some time.
Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperform AI champ Nvidia?
In this episode of Motley Fool Money, Emily Flippen, Jason Hall, and Asit Sharma to dive into three recent stories where the operating system underneath a business has started to matter more than the company above it.
Taiwan Semiconductor recently put up stellar fourth-quarter numbers, signaling that we've yet to reach peak AI demand. Are we in for another banner year in 2026?
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
